Ann: Imugene OnCARlytics Patent Allowance in China, page-59

  1. 30,527 Posts.
    lightbulb Created with Sketch. 2025
    Yeah, 3% sold by PH lol. When did YF sell his shares after the clinical trial for VAXINIA started??? Azer-Cel is 6-12 months behind Allogene's but I think it will complete registrational clinical trial faster given how the patients are selected, BP will be able to advance this faster to commercialisation and can see the low risk commercial valuation of advancement to 1st line treatment. The CR was good deal (you should look at ALA's CR released today) and it isn't your traditional CN.
    Last edited by AlCp: 26/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.5¢
Change
0.000(0.00%)
Mkt cap ! $112.0M
Open High Low Value Volume
1.5¢ 1.6¢ 1.4¢ $125.4K 8.369M

Buyers (Bids)

No. Vol. Price($)
76 17029463 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 1061875 3
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.